Clinical Trials in Austin

Showing 7741-7760 of 11,561 trials

A Study To Assess Esreboxetine's Effect On Concentration, Memory, Decision Making And Problem Solving In Patients With Fibromyalgia.

NCT00752505

The study is designed to assess if esreboxetine can improve the cognitive function of patients with fibromyalgia. Cognitive function is defined as the ability to concentrate, remember things and make decisions or problem solve. The study is also designed to assess if there is a difference in cognitive function between fibromyalgia patients and matched control subjects.

Fibromyalgia

Pfizer89 participantsStarted Aug 2008

Destin, Florida, United States • Fort Walton Beach, Florida, United States • Ann Arbor, Michigan, United States +4 more locations

COMPLETEDPhase 2< 1 mile

A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache

NCT02163993

The main purpose of this study is to evaluate whether the study drug known as galcanezumab is safe and effective in the prevention of migraine headaches.

Migraine Headache

Eli Lilly and Company414 participantsStarted Jul 2014

Gilbert, Arizona, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +37 more locations

A Study To Assess Esreboxetine's Effect On Concentration, Memory, Decision Making And Problem Solving In Patients With Fibromyalgia.

A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache

Find Trials by Condition in Austin

Clinical Evaluation of the Blazer Open-Irrigated Ablation Catheter for the Treatment of Paroxysmal Atrial Fibrillation

A Study To Assess The Safety Of PF-05335810 In Hypercholesterolemic Subjects

Real World Expanded Multicenter Study of the MitraClip® System (REALISM)

Growth and Tolerance of Young Infants

Efficacy And Safety Of Sofosbuvir/Velpatasvir Fixed Dose Combination With Ribavirin in Chronic HCV Infected Adults Who Participated in a Prior Gilead Sponsored HCV Treatment Study

Comparison of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks With Sofosbuvir and Ribavirin for 24 Weeks in Adults With Chronic Genotype 3 HCV Infection

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin for the Treatment of HCV (ION-3)

PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial

Study to Evaluate the Efficacy and Safety of MEDI9929 (AMG 157) in Adult Subjects With Inadequately Controlled, Severe Asthma

Safety and Tolerability Study of NBI-98854 for the Treatment of Tardive Dyskinesia

A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease

Safety Study of Oral Azacitidine (CC-486) as Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Participants With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS).

Safety and Efficacy of Idelalisib in Relapsed or Refractory Hodgkin Lymphoma

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 or 4 HCV and HIV-1 Co-infection

A Study of Idelalisib and Rituximab in Elderly Patients With Untreated CLL or SLL

A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus (SLE)

Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus

Ledipasvir/Sofosbuvir Fixed-Dose Combination Plus Ribavirin in Participants With Chronic HCV With Advanced Liver Disease or Post-Liver Transplant